PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Co-amoxiclav
Presentation Product Chemical substance Chapter Items dispensed
Co-amoxiclav 500mg/125mg tablets
0501013K0AAAJAJ
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 202,621
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free
0501013K0AAAGAG
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 20,212
Co-amoxiclav 250mg/125mg tablets
0501013K0AAAAAA
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 18,870
Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free
0501013K0AAADAD
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 6,685
Co-amoxiclav 125mg/31mg/5ml oral suspension
0501013K0AAAHAH
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 5,897
Co-amoxiclav 250mg/62mg/5ml oral suspension
0501013K0AAAIAI
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 5,734
Co-amoxiclav 400mg/57mg/5ml oral suspension sugar free
0501013K0AAAKAK
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 2,669
Co-amoxiclav 400mg/57mg/5ml oral suspension
0501013K0AAAPAP
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 380
Co-amoxiclav 875mg/125mg tablets
0501013K0AAANAN
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 15
Co-amoxiclav 500mg/100mg inj vials
0501013K0AAAEAE
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 5
Co-amoxiclav 1000mg/200mg inj vials
0501013K0AAAFAF
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections 4
Co-amoxiclav 250mg/125mg dispersible tablets sugar free
0501013K0AAABAB
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.